Amoxicillin Tablet, Coated
Product Images NDC 0143-9285

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amoxicillin (NDC 0143-9285). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Table 1 (Amoxicillin Tablets Usp 875 mg 1)

Table 1 (Amoxicillin Tablets Usp 875 mg 1)
This text provides dosing recommendations for the antibiotic Amoxicillin for the treatment of various bacterial infections in adult and pediatric patients over 3 months of age. The recommended doses vary depending on the severity and location of the infection, with higher doses for severe cases. The text also includes specific dosing guidance for the treatment of uncomplicated genital infections caused by Gonorrhea. Children weighing less than 40 kg should be given a lower dose, based on their weight, while those weighing over 40 kg should follow the adult recommendations.*
FDA Label Image

Structural Image (Amoxicillin Tablets Usp 875 mg 2)

Structural Image (Amoxicillin Tablets Usp 875 mg 2)
FDA Label Image

Table 3 (Amoxicillin Tablets Usp 875 mg 3)

Table 3 (Amoxicillin Tablets Usp 875 mg 3)
This is a table showing the pharmacokinetic parameters of Amoxicillin in healthy adults who were administered doses of 400mg/5mL suspension and 400mg chewable tablets. The table shows the mean values of AUC (area under the curve) and Cha (concentration of the drug in the blood) for both forms of administration. The dose was given at the start of a light meal and peak concentrations occurred approximately 1 hour after the dose.*
FDA Label Image

Bacteria (Amoxicillin Tablets Usp 875 mg 4)

Bacteria (Amoxicillin Tablets Usp 875 mg 4)
FDA Label Image

Table 4 (Amoxicillin Tablets Usp 875 mg 5)

Table 4 (Amoxicillin Tablets Usp 875 mg 5)
This is a table showing the results of two studies on the use of amoxicillin as part of a triple therapy for eradicating H. pylori infection in patients with confirmed duodenal ulcers. The table presents two types of analyses: Evaluable Analysis and Intent-to-Treat Analysis. The number of patients included in each study and the corresponding eradication rates with their respective 95% confidence intervals are provided for each analysis. The text also clarifies that patients were included in the analysis only if they had confirmed H. pylori infection at baseline and a confirmed duodenal ulcer. Any dropouts due to adverse events related to the study drug were also considered as therapy failures.*
FDA Label Image

Table 5 (Amoxicillin Tablets Usp 875 mg 6)

Table 5 (Amoxicillin Tablets Usp 875 mg 6)
FDA Label Image

Table 6 (Amoxicillin Tablets Usp 875 mg 7)

Table 6 (Amoxicillin Tablets Usp 875 mg 7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.